Cargando…
A Bio‐Liposome Activating Natural Killer Cell by Illuminating Tumor Homogenization Antigen Properties
Natural killer (NK) cell therapies, primarily based on chimeric antigen receptor NK cells (CAR‐NK), have been developed and applied clinically for therapeutic treatment of patients with mid‐to‐late‐stage tumors. However, NK cell therapy has limited efficacy due to insufficient antigen expression on...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131854/ https://www.ncbi.nlm.nih.gov/pubmed/36852735 http://dx.doi.org/10.1002/advs.202205449 |